(Picture:
CEO Jae Joon Lee(left) explaining his AI medical image reading solution to Prime
Minister Bu Gyeom Kim)
(Date:
July 30, 2021)
Crescom,
a medical AI venture company, demonstrated AI solutions at the opening ceremony
of the ‘Artificial Intelligence Convergence AI+X Project Medical Data
Utilization Demonstration Lab’ held at the Health Insurance Review and
Assessment Service Headquarters in Wonju, Gangwon-do on the 28th.
Crescom's
patented technology leads 'MediAI-BA' which is integrated the strengths of
existing bone age reading methods GP and TW3 growth plate inspection artificial
intelligence solution and 'MediAI-FX' which is the artificial intelligence
fracture detection solution. These solutions can help with timely, quick and
accurate reading in the medical field.
‘MediAI-BA’
has been confirmed to be useful in the medical field in clinical trials for
approval by the Ministry of Food and Drug Safety, and is currently helping to
analyze the age of growth plates in children in more than 100 hospitals in
Korea. ‘MediAI-FX’ can detect scaphoid fractures that cause serious sequelae
when left unattended although the fractures are usually difficult to find out.
The wrist fracture detection AI solution is currently in the final stage of
clinical trials.
In
this event, Prime Minister Bu Gyeom Kim, National Assembly member Kwang Jae
Lee, and Ki Heon Song, as well as major officials from theMinistry of Science
and ICT, the Ministry of Health and Welfare of South Korea, the Ministry of
Food and Drug Safety(MFDS), the Health Insurance Review and Assessment
Service(HIRA), and the National IT Industry Promotion Agency (NIPA) attended the
event to experience the solution demonstrations of participating companies. and
communicated with entrepreneurs.
Crescom,
specialized in musculoskeletal medical data artificial intelligence analysis
solution, was finally selected along with IDOT and JLK for the 'AI Convergence
Medical Image Reading System Construction Project' hosted by the Health
Insurance Review and Assessment Service and the Information and Communication
Industry Promotion Agency.
Crescom
formed a consortium with Seoul National University Boramae Hospital, Seoul
National University Bundang Hospital, and Korea University Anam Hospital to
develop artificial intelligence (AI) solutions for diagnosis and examination of
knee arthritis for three years. The developed solution is used to support the
diagnosis of knee degenerative arthritis in the medical field and the review of
the HIRA.
Crescom CEO Jae Joon Lee said, “Based on the support of the Ministry of Science and ICT and the Health Insurance Review and Assessment Service, we want to be helpful in the medical field and medical examination, and we will do our best to advance into the global market so that it can be widely used not only in Korea but also in overseas markets.”